Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Navy Capital is a New York-based investment management firm that specializes in the global cannabis industry, with a significant focus on the life sciences and healthcare applications of cannabinoids. The firm manages the Navy Capital Green Fund, which invests in both public and private companies across the cannabis value chain, including multi-state operators, technology providers, and biotechnology firms. Navy Capital identifies best-in-class businesses positioned to benefit from the evolving legal and regulatory landscape of medical and adult-use cannabis. By providing strategic capital and industry expertise, the firm supports the growth of companies developing innovative cannabinoid-based therapies and consumer products. Their portfolio reflects a deep commitment to the intersection of agriculture, consumer retail, and pharmaceutical science.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Navy Capital Green Management.